All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Mutual interaction of silymarin flavonolignans with human gut microbiota

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60460709%3A41210%2F25%3A102222" target="_blank" >RIV/60460709:41210/25:102222 - isvavai.cz</a>

  • Result on the web

    <a href="https://amsacta.unibo.it/id/eprint/8570/3/Book%20of%20Proceedings%201st%20INFOGUT%20ANNUAL%20MEETING%20complete%2024%2010%202025.pdf" target="_blank" >https://amsacta.unibo.it/id/eprint/8570/3/Book%20of%20Proceedings%201st%20INFOGUT%20ANNUAL%20MEETING%20complete%2024%2010%202025.pdf</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Mutual interaction of silymarin flavonolignans with human gut microbiota

  • Original language description

    Introduction. Silymarin, an extract from fruits of the milk thistle Silybum marianum (L.) Gaertn., is made up of the flavonolignans silybin A and B, isosilybin A and B, silychristin A and B, silydianin and the flavanol taxifolin. Minor components include isosilychristin, 2,3- dehydrosilybin, 2,3-dehydrosilychristin and 2,3-dehydrosilydianin. The bioavailability of silymarin components is 20–50% due to low. The aim of the study was to evaluate the complex interactions of silymarin and its components with gut microbiota both ex vivo and in vivo. Materials and Methods. Biotransformation of silymarin components was studied ex vivo, using batch incubations inoculated by fecal slurry and HPLC/MS. The interaction of the silymarin complex was investigated with a focus on aging populations. Using advanced techniques such as NGS, NMR and LC-MS, we analyzed the dual impact of the microbiome on silymarin metabolism and the effect of silymarin on the microbiome’s structure and function. Finally, in 33 healthy adult male volunteers, who received 200 mg of silymarin orally twice daily for three months, formation of metabolites in urine and feces was evaluated by HPLC/MS and bacterial composition of feces was investigated by NGS. Results and Discussion. At 200 mg/L the flavonolignans were resistant to the metabolic action of microbiota. At 10 mg/L, biotransformation of flavonolignans was much slower than that of taxifolin. Silybin, isosilybin, and 2,3-dehydrosilybin underwent mostly demethylation, silychristin was predominantly reduced. Silydianin, 2,3-dehydrosilychristin and 2,3- dehydrosilydianin were reduced and decarbonylation and cysteine conjugation proceeded. No low-molecular-weight phenolic metabolites were detected. Silymarin significantly altered the metabolism of the gut microbiota, decreasing short-chain fatty acid production and glucose utilization. Healthy elders (70–80 years) showed a significant increase in a specific catabolite associated with Oscillibacter. Conversely, healthy young donors (12–45 years) exhibited faster breakdown of silymarin components, particularly isosilybin B, which negatively correlated with higher abundance of Faecalibacterium and Erysipelotrochaceae UCG-003. In volunteers, a correlation was found between the number of metabolites and the composition of the intestinal microbiota. Conclusion. Silymarin interacts with the microbiome, influences its composition and metabolic profile. The amount of metabolites in feces depend on the composition of the gut microbiota that is responsible for large inter-individual differences

  • Czech name

  • Czech description

Classification

  • Type

    D - Article in proceedings

  • CEP classification

  • OECD FORD branch

    30308 - Nutrition, Dietetics

Result continuities

  • Project

    <a href="/en/project/GA23-04655S" target="_blank" >GA23-04655S: Role of prenylation and glycosylation patterns in anti-inflammatory activity and metabolism of natural phenolic compounds</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Article name in the collection

    Book of Conference Proceedings 1 st INFOGUT Annual Meeting

  • ISBN

    9788854972100

  • ISSN

  • e-ISSN

  • Number of pages

    2

  • Pages from-to

    16-17

  • Publisher name

    University of Bologna

  • Place of publication

    Bologna

  • Event location

    Bologna

  • Event date

    Jan 1, 2025

  • Type of event by nationality

    EUR - Evropská akce

  • UT code for WoS article